Jeffrey Wang is a Professor of Orthopaedic Surgery and Neurosurgery at the USC Keck School of Medicine, Chief of Orthopaedic Spine Service and Co-Director of the USC Spine Center. He obtained his B.S. degree with honors in Biological Sciences from Stanford University and his M.D. from the University of Pittsburgh School of Medicine. After completing his residency at the UCLA Department of Orthopaedics, he completed a spine surgery fellowship with Dr. Henry Bohlman, M.D. at Case Western Reserve University Hospitals of Cleveland. Dr. Wang is active in clinical practice, runs a spine surgery fellowship program, and has a basic science research laboratory. He is involved in cutting edge research with an emphasis on novel biologics and tissue engineering for spinal fusion and disc regeneration. Dr. Wang has been an advisor to MAX BioPharma and has collaborated with Dr. Parhami on preclinical studies involving osteogenic oxysterol molecules. Dr. Wang has been involved in several clinical trials testing both novel surgical technologies and devices, as well as growth factors and biological treatments for the treatment of human spinal disorders. He has consulted with many medical device and pharmaceutical companies and has developed novel technologies and growth factors that have been licensed for further study and development for clinical trials.